Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
369.20    -4.40 (-1.18%)
Bid:
367.60
Ask:
368.20
Spread: 0.60 (0.163%)
Market Cap: £1.96b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Hammerson Completes Refinancing Transactions

9 Oct 2024 07:00

RNS Number : 4219H
Hammerson PLC
09 October 2024
Β 

9 October 2024

HammersonΒ plc

("Hammerson" or the "Company/Group")

Hammerson completes refinancing transactions to underpin growth strategy

Following the successful issuance of its 12-year Β£400m bond, Hammerson sets out the final outcome of the new issuance and accompanying tender of the Company's outstanding bonds maturing in 2026 and 2028:

Β· 12-year Β£400m bond pricing confirmed on 3 October at a coupon of 5.875% representing a spread of 183 basis points over the reference gilt rate

Β· Strong demand led to peak order book in excess of Β£2.6bn (over 7x subscribed)

Β· The repurchase of a total of Β£411.6m bonds, comprising Β£168.4m of 6% 2026s and Β£243.2m of 7.25% 2028s

Β· An annualised net interest benefit to Hammerson of Β£3.6m1 per year (approximately Β£0.8m for the financial year ending 2024)

Β· This reduces weighted average gross interest from 3.8%2 to 3.6% and extends Hammerson's weighted average debt maturity from 2.9 years3 to 5.2 years

Β· The refinancing is largely leverage neutral; pro forma4 LTV at 30 June 2024 is 25.5% and net debt:EBITDA is 5.4x

Β 

Himanshu Raja, CFO of Hammerson plc, commented:

"The combined effect of our new Β£400m 5.875% bond maturing in 2036 and the tender of our existing short-dated sterling maturities reduces our ongoing interest costs and extends our weighted average debt maturity. The strong demand and competitive pricing are a clear recognition from investors of the strength of our portfolio, the robust balance sheet and the opportunity ahead of us."

Β 

1 Annualised interest benefit arises due to the weighted average interest cost on the bonds tendered (6% on 2026s and 7.87% on 2028s) being 7.1% and higher than the 5.875% coupon on the new issue, offset by the impact of new issue discounts and the reduction to interest receivable due to net cash outflows.

2 Weighted average gross interest rate at 30 June 2024 of 3.4% and pro forma for the refinancing of Dundrum in August 2024 of 3.8%.

3 Weighted average debt maturity at 30 June 2024 of 2.2 years and pro forma for the refinancing of Dundrum in August 2024 of 2.9 years.Β 

4 Pro forma for the tender and new issuance financing transactions and the disposal of the Group's interest in Value Retail generating net proceeds of Β£583m. Pro forma at 30 June 2024 reflecting only the disposal of the Group's interest in Value Retail; LTV was 24.7% and net debt:EBITDA was 5.3x.

Β 

ENDS

Hammerson plc

Investor Contact

Josh Warren, Hammerson, Director of Strategy, Commercial Finance and Investor Relations

Β 

Β 

Β 

+44 (0)20 7887 1053

MHP for Hammerson Media

Oliver Hughes

Ollie Hoare

Β 

+44 (0)7885 224 532

+44 (0)7817 458 804

Β 

Β 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCKZMGGKRNGDZM
Date   Source Headline
30th Apr 20247:00 amRNSDirector Declaration
25th Apr 20242:00 pmRNSResult of AGM
16th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20244:30 pmRNSHolding(s) in Company
9th Apr 202410:30 amRNSDirector/PDMR Shareholding
28th Mar 20243:15 pmRNSTotal Voting Rights
26th Mar 20243:00 pmRNSDirector/PDMR Shareholding
25th Mar 20249:00 amRNSDividend Currency Conversion Announcement
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 202411:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20242:45 pmRNSCompletion of sale of Union Square
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 202410:45 amRNSNotification of Share Repurchase Programme
6th Mar 20243:15 pmRNSHolding(s) in Company
5th Mar 20249:30 amRNSHolding(s) in Company
29th Feb 20247:01 amRNSDividend Declaration
29th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSDisposal
1st Feb 202410:30 amRNSNotification of Full Year Results
25th Jan 20249:13 amRNSDirector Declaration
8th Jan 20243:00 pmRNSHolding(s) in Company
27th Dec 202311:00 amRNSDirector Declaration
20th Dec 20239:30 amRNSHolding(s) in Company
19th Dec 202312:00 pmRNSHolding(s) in Company
15th Dec 20235:00 pmRNSHolding(s) in Company
4th Dec 202312:30 pmRNSHolding(s) in Company
30th Nov 20231:30 pmRNSHolding(s) in Company
30th Nov 202310:00 amRNSBlock listing Interim Review
17th Nov 20231:45 pmRNSHolding(s) in Company
19th Oct 20233:00 pmRNSDirector/PDMR Shareholding
17th Oct 20239:00 amRNSDirector/PDMR Shareholding
11th Oct 20233:45 pmRNSDirector/PDMR Shareholding
9th Oct 20234:15 pmRNSDirector/PDMR Shareholding
6th Oct 20234:00 pmRNSDirector/PDMR Shareholding
5th Oct 20234:00 pmRNSDirector/PDMR Shareholding
20th Sep 20239:00 amRNSHolding(s) in Company
8th Sep 20231:10 pmRNSResults of bond tap issuance and tender offer
8th Sep 20231:00 pmRNSFinal Results of Bond Tender Offers
8th Sep 20239:00 amRNSIndicative Results of Bond Tender Offers
5th Sep 20239:00 amRNSHolding(s) in Company
31st Aug 202312:30 pmRNSHammerson Issues £100m Bond Tap
31st Aug 202311:15 amRNSBond Tender Offers
22nd Aug 20232:45 pmRNSHolding(s) in Company
21st Aug 20233:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.